植物抗肿瘤活性成分鬼臼毒素化学改造后的代表药物依托泊甙(etoposide)等自70年代进入临床后,不论其疗效和毒副反应均有不足之处。因此,进一步对鬼臼毒素母核 Plant anti-tumor active ingredient podophyllotoxin after the chemical modification of the representative drug etoposide (etoposide) entered the clinic since the 1970s, regardless of its efficacy and toxicity are inadequate. Therefore, further podophyllotoxin mother nucleus